Bortiva 3.5mg Injection

Welcome to the information page for Bortiva 3.5mg Injection, brought to you by GLS Pharma Ltd.. This product contains the active ingredient Bortezomib (3.5mg) and is indicated for Multiple myeloma,Mantle-cell lymphoma. Here, you can find crucial details, including its uses, pricing, and options to add it to your wishlist or compare it with similar medications.

MRP: ₹ 8500
Packing: 1.0 Injection in 1 vial
Salt Combination: Bortezomib (3.5mg)
Brand: GLS Pharma Ltd.
Uses: Multiple myeloma,Mantle-cell lymphoma

Description

Bortiva 3.5mg Injection is used in the treatment of multiple myeloma and mantle-cell lymphoma
It shows its working by stopping or slowing down the growth of cancer cells
Bortiva 3.5mg Injection is given as an injection by a qualified medical professional
Your doctor will decide what dose is necessary and how often you need to take it
This will depend on what you are being treated for and may change from time to time
You should take it exactly as your doctor has advised
Taking it in the wrong way or taking too much can cause very serious side effects
It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
Fatigue, nausea, vomiting, and loss of appetite are some common side effects of this medicine
You may be advised to drink plenty of fluids every day during the treatment
You should not drive or operate machinery as medicine may cause tiredness and dizziness
This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections
Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels.
Before taking Bortiva 3.5mg Injection, consult with your doctor if you have any liver, kidney, heart disease or bleeding problem
It is important to consult a doctor if you develop symptoms like memory loss or trouble in thinking
Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using
This medicine is not recommended during pregnancy or while breastfeeding
The use of effective contraception by both males and females during treatment is important to avoid pregnancy.

Cautions

Liver:	CAUTION: Bortiva 3.5mg Injection should be used with caution in patients with liver disease. Dose adjustment of Bortiva 3.5mg Injection may be needed. Please consult your doctor.
Kidney:	CAUTION: Bortiva 3.5mg Injection should be used with caution in patients with severe kidney disease. Dose adjustment of Bortiva 3.5mg Injection may be needed. Please consult your doctor.
Driving:	UNSAFE: Bortiva 3.5mg Injection may cause side effects which could affect your ability to drive.^Bortiva 3.5mg Injection might cause tiredness, dizziness, fainting, or blurred vision which may affect your ability to drive.
Breast feeding:	UNSAFE: Bortiva 3.5mg Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Pregnency:	CONSULT YOUR DOCTOR: Bortiva 3.5mg Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Alcohol:	UNSAFE: Bortiva 3.5mg Injection may cause excessive drowsiness with alcohol.
Drug Action:	Proteasome inhibitor
Therapeutic class:	ANTI NEOPLASTICS
Habit Forming:	No
Chemical Class:	Phenylalanine Derivatives